Assessment of the Performance of Magnetic Resonance Imaging/Ultrasound Fusion Guided Prostate Biopsy against a Combined Targeted Plus Systematic Biopsy Approach Using 24-Core Transperineal Template Saturation Mapping Prostate Biopsy

Table 1

Baseline characteristics of MRI/US fusion targeted biopsy cohort.

	All patients ()	Patients with both MRI/US-TBx + TTMB ()
Age (median, IQR)	65 (60–70)	64 (59–69)
PSA (median, IQR)	5.0 (3.6–7.5)	5.2 (3.8–7.5)
Prostate volume (median, IQR)	44 (34–60)	42 (32–59)
Positive DRE, (%)	23 (16%)	12 (15%)
Patients with previous biopsy, (%)	55 (37%)	15 (19%)
Positive biopsy in the past, (%)	24 (16%)	8 (10%)
Negative biopsy in the past, (%)	34 (23%)	7 (9%)
ROI size in mm	7 (5–10)	7 (5–10)
Number of cores taken per location (Median, IQR)	4 (3–5)	4 (3-4)

IQR = interquartile range, = number, mm = millimetres, MRI/US-TBx = MRI/transrectal ultrasound fusion targeted biopsy, and TTMB = transperineal template guided mapping biopsy.